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Ventilation/Perfusion SPECT Imaging—
Diagnosing Other Cardiopulmonary Diseases
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Ventilation/perfusion single-photon emission computed tomography (V/P SPECT) is the scin-*Ska

ne University Ho
Hospital Lund, Lu
yDepartment of Pulm
University Hospita
Address reprint reque
Ska

ne University H
Marika.Bajc@med
1Guest Editor’s note: W
the abbreviation “V
scanning, the term
Europe. “V/P” and
been retained here
4 https://doi.org/
0001-2998/©tigraphic technique recommended primarily for the diagnosis of acute pulmonary embolism
(PE) and is golden standard for the diagnosis of chronic PE. Furthermore, interpreting ventila-
tion and corresponding perfusion images enables pattern recognition of many other cardio-
pulmonary disorders that affect lung function and also allows quantification of their extent.
Using Technegas for the ventilation imaging, grading of small airway disease in COPD is pos-
sible and the method is recommended for PE diagnosis in patients with severe COPD that is
not possible with radiolabelled liquid aerosols. An optimal combination of nuclide activities,
acquisition times for ventilation and perfusion, collimators, and imaging matrix yields an ade-
quate V/P SPECT study in approximately 20 minutes of imaging time. The holistic interpreta-
tion strategy of V/P SPECT uses all relevant information about the patient and ventilation/
perfusion patterns. PE is diagnosed when there is more than one subsegment showing a V/P
mismatch representing an anatomic lung unit. Apart from PE, other pathologies should be
identified and reported, such as obstructive lung disease, heart failure, and pneumonia
according to the European Association of Nuclear Medicine guidelines.
Semin Nucl Med 49:4-10 © 2018 Published by Elsevier Inc.Overview of Ventilation/
Perfusion SPECT1
Ventilation/Perfusion SPECT (V/P SPECT) is the recom-mended method for the diagnosis of pulmonary embo-
lism (PE) and it should be used whenever possible.1 Apart
from PE, other changes can be identiﬁed and reported, such
as the signs of chronic obstructive pulmonary disease
(COPD), pneumonia, left heart failure, chronic PE, pulmo-
nary hypertension and suspicion of other parenchymal pro-
cesses like tumors.2-6 Recent studies have shown that for thespital, Department of Clinical Sciences, University
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2018 Published by Elsevier Inc.ventilation study, Technegas particles have an advantage
over radiolabeled liquid aerosols due to the better penetra-
tion to the periphery of the lung. Therefore, Technegas ena-
bles studies in patients with obstructive lung disease.7
Radiolabeled macroaggregated human albumin is the imag-
ing agent of choice for perfusion scintigraphy. An adequate
V/P SPECT acquisition starting with ventilation and continu-
ing with perfusion can be done in 20 minutes by using an
optimal combination of radionuclide activities, collimators,
and imaging matrix. It is recommended that the 1-day proto-
col starts with a ventilation examination, immediately fol-
lowed by perfusion.8 This allows for presentation of
matching ventilation and perfusion slices in all projections. It
also allows for rotating volume images based upon maximum
intensity projections and quantiﬁcation of V/P Quotient. V/P
SPECT should be interpreted according to the European
Association of Nuclear Medicine guidelines.V/P SPECT Acquisition
Administration of the ventilation and perfusion agents should
always be performed in the same position, preferably supine.
Table 1 Optimization of Ventilation and Perfusion Examinations in V/P SPECT
Ventilation Perfusion
Administration Inhalation IV injection
Radiopharmaceutical and
administered activity
[99mTc]-Technegas 25-30 MBq to
reach the lungs
[99mTc]-MAA 120-160 MBq
particle size 0.09 mm 15-100 mm
Time of Imaging Approx 11 minutes Approx 5 minutes
Acquisition protocol General purpose collimator: 64£ 64
matrix, 60-64 steps for each head, 10
sec/step
General purpose collimator: 64£ 64 matrix,
60-64 steps for each head, 5 sec/step
Reconstruction Iterative reconstruction—eight subsets
and four iterations
Iterative reconstruction—eight subsets and
four iterations
Ventilation/Perfusion SPECT Imaging 5During inhalation, activity over the lungs should be monitored
to ensure adequacy of pulmonary activity deposition. The
procedure starts with ventilation scintigraphy. Large particles
(>2 mm) are deposited mainly by impaction in large airways.
Very ﬁne particles, <1 mm, are mainly deposited in alveoli by
diffusion. In comparison to radiolabeled liquid aerosols, Tech-
negas shows signiﬁcantly improved outcomes with deposition
of radioaerosol in central airways and better penetration to the
lung periphery, which is important for patients with obstruc-
tive airways disease. Thus, it enables a correct diagnosis of PE
even in obstructive patients and its use is generally
recommended.3,7,9
Perfusion tomography follows immediately after ventila-
tion SPECT without changing the patient’s position. After
intravenous injection, the particles of size 15-100 mm are
lodged in the pulmonary capillaries and in the precapillary
arterioles in proportion to the perfusion.
To achieve adequate imaging quality with low radiation
exposure in a short time, relationships between radioactiv-
ities, acquisition times, collimators, and matrices for SPECT
imaging must be optimized. This problem has beenFigure 1 Overview of ventilation and perfusion SPECT images
are carefully aligned to each other.systematically analyzed.8 Doses of 25-30 MBq for ventilation
studies and 120-160 MBq for perfusion studies were found
to be optimal by using a general purpose collimator and
64£ 64 matrix. The total acquisition time is about 20
minutes. If a matrix of 128£ 128 is used, higher doses and/
or longer acquisition times are required. This is not pro-
moted as it does not yield images of signiﬁcantly higher qual-
ity. To follow the good medical practice, radiation exposure
should be minimized to the lowest level consistent with satis-
factory image quality (Table 1).
When low-activity doses are used for V/P SPECT, as in the
case of the pregnant or young female, it is essential to use an
optimized iterative reconstruction. It is recommended to use
ordered-subset expectation maximization with four iterations
and eight subsets. Standard software can be used for the image
presentation in coronal, sagittal, and transversal projections as
well as for the presentation of rotating 3D images.8
We have developed a program to calculate and to display
ventilation/perfusion quotient images to facilitate the image
interpretation. For this purpose, ventilation is normalized to per-
fusion counts, and then the V/P quotient images are calculated.in coronal and sagittal slices. Ventilation and perfusion
Figure 2 Patient with severe COPD and PE. Coronal slices: uneven
distribution of ventilation with deposition of aerosols in small air-
ways. Multiple perfusion defects are seen bilaterally (red arrows).
COPD, chronic obstructive pulmonary disease; PE, pulmonary
embolism.
Figure 3 Patient with severe COPD, emphysema, and PE. Corona
and sagittal slices: uneven distribution of ventilation with centra
deposition of aerosols indicating severe degree of airway obstruc-
tion. In the right upper lobe is area with absent ventilation (better
preserved perfusion), emphysema (green arrow). Corresponding
perfusion images (middle row) show segmental perfusion defects
(red arrows), PE, in the ventilated areas, well delineated on V/P quo-
tient image. COPD, chronic obstructive pulmonary disease; PE, pul-
monary embolism.
6 M. Bajc and A. LindqvistV/P quotient images facilitate also quantiﬁcation of PE extent.
Using this protocol, attenuation correction is not required.8,10
An overview of ventilation and perfusion in coronal and
sagittal slices is useful for quality control and fast orientation
regarding pulmonary pathology. It is important to present
the matched images so that ventilation and perfusion are
carefully aligned to each other (Fig. 1). This is greatly facili-
tated by the one session protocol with the patient in an
unchanged position. The option to triangulate coronal, sagit-
tal, and transverse slices is valuable for identiﬁcation of
matching and nonmatching ventilation and perfusion
changes. Proper alignment is also a prerequisite for V/P quo-
tient images. V/P quotient images facilitate recognition of
mismatch and “reverse mismatch” patterns. This is important
for the interpretation and quantiﬁcation of the PE extent and
for all ventilation and perfusion defects. However, quotient
images are not a prerequisite for a high-quality V/P SPECT.Holistic Interpretation
For V/P SPECT, interpretation criteria are as important as the
imaging technique itself. In the holistic interpretation, all patterns
of ventilation and perfusion as well as numbers of defects are
described and interpreted and clinical probability is considered.
The holistic interpretation gives a clear answer; yes or no regard-
ing PE. Large V/P SPECT studies have shown conclusive reports
in 96%-99% of cases.11-15 This goal was not achieved with previ-
ous probabilistic criteria (PIOPED 1 and modiﬁed PIOPED).16,17
PE is diagnosed when there is more than one segment or two
subsegments, showing a ventilation/perfusion mismatch repre-
senting an anatomic lung unit. Apart from PE, other pathologies
should be identiﬁed and reported, such as broncho-obstructive
disease, left heart failure, pneumonia, and suspicion of other
parenchymal processes like tumors. Pitfalls exist both with
respect to the imaging technique and scan interpretation.1,18Chronic Obstructive Pulmonary Disease
COPD is frequently observed in patients suspected of PE,
because COPD patients are at a higher risk of PE.2,9,11 Thel
lrate of PE in patients hospitalized for acute exacerbation of
COPD may be as high as 25%. PE accounts for up to 10% of
deaths in stable COPD patients. Different to the PIOPED
study, PE can be diagnosed even in the presence of COPD
with V/P SPECT.
The characteristic of COPD is a general unevenness of ven-
tilation. The degree of ventilation defect reﬂects varying
severity of small airway disease and emphysema typical for
COPD.2,3,9,11,19,20 Emphysema is characterized by areas of
absent/decreased ventilationwith usually less pronounced perfu-
sion defects (reverse mismatch).3,21 Focal deposition of aerosol
in central or peripheral airways may even locate sites of airway
obstruction.19 The degree of unevenness of aerosol distribution
correlates with lung function tests.3,22,23 The method gives the
possibility to localize ventilation and perfusion impairment and
also estimate total lung function.24 It is noteworthy that there are
no contraindications to V/P SPECT and that even very sick and
breathless patients can be studied. Figure 2 shows coronal slices
in a patient with a severe COPD and PE. Figure 3 shows coronal
and sagittal slices in a patient with severe COPD, emphysema,
and PE. The grading of obstruction in ventilation SPECT has
been standardized (Fig. 4).
- Grade 1: Uneven radioaerosol distribution through the
lung.
- Grade 2: Uneven radioaerosol distribution and reduced
Technegas penetration to the periphery, with deposition
of radioaerosols in small airways, seen as hot spots.
Figure 4 Degree of airway obstruction. Coronal slices: ventilation
and corresponding perfusion images; normal pattern, mild, moder-
ate, and severe COPD. COPD, chronic obstructive pulmonary dis-
ease.
Figure 5 Patient with pneumonia and PE in the right lung. Sagittal sli-
ces: reduced/absent ventilation posteriorly with reduced perfusion in
the same area. Preserved perfusion adjacent to the pleura, “stripe
sign” (blue arrow). In the middle lobe, perfusion defect is seen (red
arrow) in the ventilated area.
Ventilation/Perfusion SPECT Imaging 7- Grade 3: Severely impaired Technegas penetration to
the lung periphery and a central deposition of Techne-
gas in large airways, usually with large areas of
reduced/absent ventilation.
Moreover, V/P SPECT has a high sensitivity to showing an
obstructive pattern in the lungs of many apparently healthy
smokers2.Pneumonia
Pneumonia is also frequent ﬁnding in patients investigated
for suspected PE. Figure 5 shows a patient with pneumonia
and PE. Pneumonia is here a general term for conditions of
lung inﬂammation often caused by a bacterial, viral, or fungal
infection, where blood biomarkers are not sufﬁcient in diag-
nosing pneumonia. Nonspeciﬁc clinical symptoms can lead
to diagnostic problems.25,26
In pneumonia, V/P SPECT shows ventilation defects,
which usually exceed perfusion defects known as reverse
mismatch (reversed V/P mismatch).27,28 Preserved perfusion
along the pleural border peripheral to a central matched
defect often termed a “stripe sign” is a speciﬁc characteristic
of pneumonia (Fig. 5).29 In a recent study that has followed
patients with PE and pneumonia both clinically and with V/P
SPECT, ventilation/perfusion changes typical for pneumonia
and PE has normalized, conﬁrming the diagnoses.2 Dys-
pnoea was a common symptom in these patients. It can be2Work in progress by the authors, presented at Eur Respiratory Society
Annual Congress 2018caused by pneumonia as well as by PE or COPD. In some
patients, V/P defects typical for pneumonia reduce the total
lung function in the absence of any morphologic CT
changes. Frequently, pneumonia is comorbid with PE. In
these clinical scenarios, PE is frequently missed by CT.2,30
This is important information because in general, current
clinical and nuclear medicine practices do not recognize nor
use V/P SPECT as a potential imaging method to diagnose or
manage pneumonia.
Left Heart Failure
Antigravitational perfusion distribution from the posterior to
anterior region indicates pulmonary congestion. The pattern
was described already in 196631 and studied later.2,4,32-34 As
ventilation is usually less affected, the typical pattern is an
antigravitational redistribution of perfusion and V/P mis-
match in dorsal regions of the lung. This V/P mismatch has a
nonsegmental pattern (does not conform to pulmonary vas-
cular architecture) and should not be misinterpreted as PE.
Figure 6 shows a patient with nonsegmental mismatch. The
positive predictive value 88% for heart failure has been
reported.4 The power of V/P SPECT for diagnosis of heart
failure was recently conﬁrmed with regard to right heart
catheterisation.34
Chronic PE
Chronic PE represents a condition in which pulmonary
emboli do not resolve and the clinical presentation is
often insidious. Chronic PE may be a progressive disease
that develops in about 1%-5% of patients after an acute
episode of PE, even in patients who have been treated.35-
38 It might be a consequence of repeated frequently
Figure 7 Patient with chronic pulmonary embolism. Sagittal slices:
uneven ventilation. The corresponding perfusion images show
hyperperfusion in the central part of the lung. Perfusion defects (red
arrows) around the lung, clearly visible on V/P quotient images.Figure 6 Patient with left heart failure. Sagittal slices: Antigravita-
tional distribution of ventilation and more so of perfusion, causing
nonsegmental V/P mismatch in the dorsal regions (black arrows).
8 M. Bajc and A. Lindqvistunrecognized small pulmonary emboli.39 It may also lead
to chronic thromboembolic pulmonary hypertension
(CTEPH), right heart failure, and arrhythmia, which are
frequent causes of death.
The value of V/P scintigraphy in this situation is well estab-
lished but underutilized for this important diagnosis.4041
This has been conﬁrmed in a head-to-head comparison
between X-ray CT Pulmonary Angiography (CTPA) and pla-
nar scintigraphy with pulmonary angiography as a reference.
Among patients with pulmonary hypertension, scintigraphy
had a sensitivity of 96% and speciﬁcity of 90%, whereas
CTPA had a sensitivity of 51%.42 Soler et al conﬁrmed that
V/P SPECT had a higher sensitivity compared with CTPA.43
For exclusion of CTEPH, V/P scintigraphy is the imaging test
of choice.38
Pulmonary scintigraphy might also be able to differentiate
among different types of CTEPH. A predominantly central
subtype of CTEPH can be treated with a pulmonary endar-
terectomy. A predominantly peripheral subtype is not opera-
ble (Fig. 7). Sensitivity for detecting thromboembolic
segments was signiﬁcantly higher for V/P planar scintigraphy
compared with CTPA: 96%-97.4% vs 51%, speciﬁcity 90%-
95% vs 99%.42 In central disease, the sensitivity of V/P
SPECT was signiﬁcantly higher than the sensitivity for V/P
planar scintigraphy (63.5% § 3.1% vs 42.7% § 3.2%). The
speciﬁcities of these two imaging modalities were not signiﬁ-
cantly different. In a similar setting, sensitivity of V/P SPECT
was 62.0% § 4.1% and that of CTPA 47.8% § 2.9%.43
Dual-energy CT perfusion and angiography, using a single
acquisition, shows only moderate agreement (K = 0.44) with
scintigraphy on the segmental level. Agreement between
CTPA and scintigraphy ranged from fair (K = 0.31) to slight(K = 0.09).44 In the treatment planning, even V/P SPECT
under-represents the true extent of vascular obstruction from
CTEPH.43 Dual-energy CT is not able to supplement this
information gap.Conclusion
To take full advantage of the V/P SPECT potential, it is cru-
cial to apply an optimal protocol for a single-session imaging
of both ventilation and perfusion. This should be done by
using low nuclide activities and by making a holistic inter-
pretation.
Ventilation SPECT can be used to classify small airway dis-
ease in COPD. Together with perfusion SPECT, it can be
used to evaluate the parenchymal damage (emphysema) in
COPD. Ventilation and perfusion SPECT can be used to
diagnose pneumonia and pulmonary congestion. To quantify
pulmonary function, it is essential to measure ventilation and
perfusion.
It is important to underline that using V/P SPECT, PE can
be diagnosed in the presence of COPD and other pulmonary
comorbidities. These advantages of V/P SPECT make it a
suitable and desirable technique for diagnosing and follow-
ing up PE. It is also an ideal technique to diagnose and follow
up cardiopulmonary diseases like COPD, pneumonia, and
left heart failure, which often cause similar kind of symptoms
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